 |
 |
 |
 |
 |
 |
|
Papers and Conference Presentations |
Title and Forum |
Date |
 |
Analyzing the Legal Impact of Apotex Inc. v. Sanofi-Synthelabo Canada Inc. on Obviousness and Selection Patents One Year Later. Paper delivered at “8th Annual Forum on Pharma Patents”, The Canadian Institute |
October 29, 2009 |
Ed Hore presents on "Generic vs. Innovator - Recent Cases" panel discussion at “Drug Patents and Legal Forum”, Insight Information |
February 27, 2008 |
Some Comments on the Regulatory Amendments to the Patented Medicines (Notice of Compliance) Regulations and the AstraZeneca decision, One Year Later. Paper delivered at “6th Annual Forum on Pharma Patents”, The Canadian Institute |
October 17, 2007 |
Recent Changes in the Law Affecting Generic Drug Market Entry, and the Impact for Drug Prices. Paper delivered at “Drug Pricing and Reimbursement Conference”, The Canadian Institute |
June 5, 2007 |
Trade-mark Opposition Proceedings: An Overview. Paper delivered at “More Than Simply Inserting an “®” Symbol”, Ontario Bar Association |
May 10, 2007 |
2006 Amendments to the Patented Medicines (Notice of
Compliance) Regulations and the Food and Drug Regulations. Paper delivered at “5th Annual Forum on Pharma Patents”, The Canadian Institute |
October 16, 2006 |
Update on proposed amendments to the Patented Medicines
(Notice of Compliance) Regulations and the Food and Drug Regulations. Paper delivered at “4th Annual Forum on Pharma Patents”, The Canadian Institute |
October 18, 2005 |
Bill C-9: An Act To Amend The Patent Act and The Food And Drugs Act – A Model
For The World But Is It Workable?. Paper Delivered at "Pharma Patents," The Canadian Institute |
November 9-10, 2004 |
“Evergreening” under the Patented Medicines (Notice of Compliance) Regulations. Paper Delivered at “Drug Patents: The Latest Legal, Policy and Strategic Developments”, Insight Information Co. |
March 29, 2004 |
PATENTLY ABSURD: Evergreening of pharmaceutical patent protection under the Patented Medicines (Notice of Compliance) Regulations of Canada’s Patent Act |
2004 |
Two Policy Limits on Trade-Mark "Monopolies". Paper Delivered at "The Six-Minute Intellectual Property Lawyer for General Practitioners and IP Professionals," Law Society of Upper Canada, Toronto |
November 7, 2003 |
Are the Patented Medicines (Notice of Compliance) Regulations Working? Paper delivered at "Drug Patents: The Latest Developments and Strategies," Insight Conference Co. Conference, Toronto |
March 28, 2003 |
The Patented Medicines (Notice of Compliance) Regulations: What Patents are Eligible to Be Listed on the Register? Paper delivered at Pharma Patents Conference, Canadian Institute Conference, Toronto |
October 24, 2002 |
Are the Patented Medicines (Notice of Compliance) Regulations Working? Paper delivered at "Drug Patents," Insight Information Co. Conference |
March 5 , 2002 |
Update on Domain Names, Talk delivered at Ontario Bar Association, Technology Section Meeting |
October 17 , 2001 |
Panelist, 9th Annual PHARMAC Conference, Canadian Institute, Toronto |
March 26-27, 2001 |
A Comparison of United States and Canadian Laws as they Affect Generic Pharmaceutical Market Entry, Food and Drug Law Journal, Vol 55, no. 3, p. 373, Food and Drug Law Institute, Washington, DC. |
2000 |
Enforcing or Litigating IP/IT Rights, Paper delivered at Canadian Bar Association Continuing Legal Education Conference on "Internet Commerce and Cyberlaw" |
October 24, 1998 |
Going to Court: Practical Concerns in Litigating the IP/IT Claim, Paper delivered at "Intellectual Property in the Digital Universe," Infonex Conference |
June 22 and 23, 1998 |
Member of Panel on "The Aftermath and Lessons Learned from Bill C-91 -Not Business as Usual," Canada's Pharmaceutical Industry Conference (CPIC) |
October 20-22, 1997 |
"Proprietary Information and Access to Information," Paper Delivered By Edward Hore at Conference on "Intellectual Property in the Public and Quasi-Public Sectors," The Canadian Institute. (Hard copy available on request) |
April 12, 1995 |
"The Notice of Compliance Regulations Under the Patent Act: The First Two Years," 12 Canadian Intellectual Property Review 209 |
(Hard copy available on request) |
"What's in a Name? Clara Brett Martin was a) Canada's first woman lawyer, b) a feminist idol, c) the name on the new Ontario law building, d) an anti-semite, e) all of the above." Saturday Night magazine |
April, 1992 |
"Caught in the Act: Human Rights Commissions are supposed to deliver us from discrimination. But mired as they are in bureaucracy, backlogs, and refinements, how can they possibly work?" Saturday Night magazine |
September, 1989 |
"Open House: Forget the Charter of Rights. Nowadays, government officials can snoop around your home almost whenever they please." Saturday Night magazine |
September, 1988 |
 |
|
|
 |
|